Overview

Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of the Test Product, Nitisinone 10 mg Tablet, under fasting and fed conditions (food-effect).
Phase:
Phase 1
Details
Lead Sponsor:
Cycle Pharmaceuticals Ltd.
Collaborator:
Parexel
Treatments:
Nitisinone